MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-KL-02-0006279
Kainopharm Limited
Kainopharm Limited - pharma in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.66 Cr
▲ 16% YoY
Net profit · FY 2025
₹6.54 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹11.09 Lakh
EBITDA margin 4.2%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.93 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
14
As per MCA filings
Active GSTINs
1
GST registered
About Kainopharm Limited
Data last updated:
Kainopharm Limited is a public limited company based in Ernakulam, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U33100KL2020PLC063719. Its GSTIN is 32AAICK2445A1Z4 (Kerala).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.93 Cr. It is led by directors including Ponnath Sathyapalan (Managing Director) and Attupuram Sreekumar.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #229/A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹6.54 Lakh (net margin 2.5%) and EBITDA of ₹11.09 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
Court records list 5 cases involving the company, including 5 filed by the company; 4 cases are pending.
Kainopharm Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0006279).
Company details
CIN U33100KL2020PLC063719
Registration Number 063719
Incorporation Date 19 August 2020
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0006279
Key People
Ponnath Sathyapalan Managing Director Attupuram Sreekumar Director Mohanakurup Anjiliparambil Narayanapillai Director Recognitions & Rankings of Kainopharm
Contact details
Kainopharm Limited's registered office is in Ernakulam, Kerala. Its e-mail address is in the company report.
- Email
- Registered Address#229/A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kainopharm Limited, buy the company report.
Comprehensive company report
Kainopharm Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kainopharm is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kainopharm Limited, buy the company report.
Financials of Kainopharm Limited
FY 2025 filings availableKainopharm Limited reported revenue of ₹2.66 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹2.66 Cr ▲ 16%
Net profit · FY 2025
₹6.54 Lakh margin 2.5%
EBITDA · FY 2025
₹11.09 Lakh margin 4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 36%
Revenue rose 16% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kainopharm Limited, buy the company report.
Board of directors of Kainopharm Limited
Kainopharm has 14 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Attupuram Sreekumar Also directs: Attupuram Engineering Company Private Limited | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
| Mohanakurup Anjiliparambil Narayanapillai Also directs: Pioneerpoonam Pharma LLP | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Valiyakath Anwar | Director | 15 Nov 2020 | 5 Years 11 Months | Current |
| Ravi Sankunny Menon Also directs: Biz Impact Nidhi Limited | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Telny Thomas Chungath | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
| Anitha | Director | 15 Nov 2020 | 5 Years 11 Months | Current |
Showing 6 of 14 current directors. View all directors
Peer comparison
Kainopharm Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raintree Dealers Private Limited | ₹2.67 Cr (FY 2016) | Kolkata, West Bengal, India | ||||
| Dipan Pharmachem Private Limited | ₹2.67 Cr (FY 2023) | Ahmedabad, Gujarat, India | ||||
| Ilkka Healthcare Private Limited | ₹2.66 Cr (FY 2025) | 38.0% | Bangalore, Karnataka, India | |||
| NH Infraventures Private Limited | ₹2.66 Cr (FY 2019) | 30.0% | Lucknow, Uttar Pradesh, India | |||
| Orangesun Multitrade Private Limited | ₹2.66 Cr (FY 2022) | 258.0% | Mumbai, Maharashtra, India | |||
| Kainopharm Limitedthis company | ₹2.66 Cr (FY 2025) | ₹6.54 Lakh | 2.5% | 16.0% | Ernakulam, Kerala, India | |
| Itouch Dental Labs Private Limited | ₹2.66 Cr (FY 2025) | 16.0% | Chennai, Tamil Nadu, India | |||
| Sumarrow Ceramica Private Limited | ₹2.66 Cr (FY 2024) | -52.0% | Morbi, Gujarat, India | |||
| Mamta Structures Private Limited | ₹2.66 Cr (FY 2024) | 44.0% | Kolkata, West Bengal, India | |||
| Edxport Trade Private Limited | ₹2.66 Cr (FY 2024) | 212.0% | Bhopal, Madhya Pradesh, India | |||
| PM Agro Biotech Private Limited | ₹2.66 Cr (FY 2025) | 122.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Kainopharm Limited, buy the company report.
Legal cases
Kainopharm Limited has 5 court cases on record: 5 filed by Kainopharm. 4 cases are pending and 1 is disposed.
Total cases
5
Filed by the company
5
Pending
4
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 4 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ernakulam, Kerala | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ernakulam, Kerala | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ernakulam, Kerala | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ernakulam, Kerala | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ernakulam, Kerala | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Kainopharm Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kainopharm Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kainopharm Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Kainopharm has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICK2445A1Z4 | Kerala | Active | 11 Oct 2020 |
To see the full GST registrations and return filing status of Kainopharm Limited, buy the company report.
Recent activity
Kainopharm Limited has 26 board changes on record since 2020: 14 appointments and 12 cessations. The latest: Ponnath Sathyapalan ceased to be Director on 31 Mar 2025.
AGM
Kainopharm Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Kainopharm Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Ponnath Sathyapalan ceased to be Director.
Ceased
Mohanakurup Anjiliparambil Narayanapillai ceased to be Managing Director.
Ceased
Abdul Latheef ceased to be Additional Director.
Ceased
Anilkumar Bhaskaran Nair ceased to be Additional Director.
Ceased
Anitha ceased to be Additional Director.
Ceased
Attupuram Sreekumar ceased to be Additional Director.
Ceased
Kuzhalmannam Lakshminarayanan Sreeram ceased to be Additional Director.
Ceased
Panikkath Sukesh ceased to be Additional Director.
Ceased
Rajesh ceased to be Additional Director.
Ceased
Suresh Krishna Warrier ceased to be Additional Director.
17 earlier events are in the company report.
Frequently asked questions
Kainopharm is an active public limited company based in Ernakulam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2020 (6+ years old) and is registered under CIN U33100KL2020PLC063719.
Kainopharm has 14 current directors:
- Ponnath Sathyapalan - Managing Director
- Attupuram Sreekumar - Director
- Mohanakurup Anjiliparambil Narayanapillai - Director
- Valiyakath Anwar - Director
- Ravi Sankunny Menon - Director
- Telny Thomas Chungath - Director
- Anitha - Director
- Rajesh - Director
- Kuzhalmannam Lakshminarayanan Sreeram - Director
- Abdul Latheef - Director
- Suresh Krishna Warrier - Director
- Jaison George - Director
- Sasidharan Madhavan - Director
- Anilkumar Bhaskaran Nair - Director
The latest financial statements of Kainopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Kainopharm is 32AAICK2445A1Z4, registered in Kerala.
The CIN (Corporate Identification Number) of Kainopharm is U33100KL2020PLC063719. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kainopharm has 5 court cases on record: 5 filed by the company. 4 are pending.
Kainopharm was incorporated on 19 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Kainopharm by revenue are Raintree Dealers Private Limited, Dipan Pharmachem Private Limited, Ilkka Healthcare Private Limited, NH Infraventures Private Limited, Orangesun Multitrade Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ponnath Sathyapalan ceased to be Director on 31 Mar 2025. Mohanakurup Anjiliparambil Narayanapillai ceased to be Managing Director on 30 Mar 2025. Abdul Latheef ceased to be Additional Director on 06 Nov 2021. Kainopharm has 26 board changes on record in total.
Yes, Kainopharm is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0006279).
The registered office of Kainopharm is at #229A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308.